[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Spikes et al., 1995 - Google Patents

A comparison of the photoproperties of zinc phthalocyanine and zinc naphthalocyanine tetrasulfonates: model sensitizers for the photodynamic therapy of tumors

Spikes et al., 1995

Document ID
10800480011632278038
Author
Spikes J
van Lier J
Bommer J
Publication year
Publication venue
Journal of Photochemistry and Photobiology A: Chemistry

External Links

Snippet

Phthalo-and naphthaocyanines are of interest as sensitizers for the photodynamic therapy of tumors because of their strong absorption in the 680 and 760 nm ranges respectively. Both zinc phthalocyanine and naphthalocyanine tetrasulfonates (ZnPcS4 and ZnNcS4) were …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0009Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation
    • A61K41/0019Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation by UV, IR, Rx or gamma rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy

Similar Documents

Publication Publication Date Title
Spikes et al. A comparison of the photoproperties of zinc phthalocyanine and zinc naphthalocyanine tetrasulfonates: model sensitizers for the photodynamic therapy of tumors
Wagner et al. Biological activities of phthalocyanines—VI. Photooxidation of L‐tryptophan by selectively sulfonated gallium phthalocyanines: singlet oxygen yields and effect of aggregation
Rosenthal et al. Role of oxygen in the phototoxicity of phthalocyanines
Spikes et al. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors
Hadjur et al. Spectroscopic studies of photobleaching and photoproduct formation of meta (tetrahydroxyphenyl) chlorin (m-THPC) used in photodynamic therapy. The production of singlet oxygen by m-THPC
Moan et al. Photobleaching of protoporphyrin IX in cells incubated with 5‐aminolevulinic acid
Spikes et al. Zinc tetrasulphophthalocyanine as a photodynamic sensitizer for biomolecules
Brasseur et al. Biological activities of phthalocyanines–III. Photoinactivation of V‐79 Chinese hamster cells by tetrasulfophthalocyanines
Ericson et al. A spectroscopic study of the photobleaching of protoporphyrin IX in solution
Dąbrowski et al. Synthesis, photophysical studies and anticancer activity of a new halogenated water‐soluble porphyrin
Hadjur et al. Production of the free radicals O.-2 and. OH by irradiation of the photosensitizer zinc (II) phthalocyanine
Andley et al. Generation of oxidants in the near-UV photooxidation of human lens alpha-crystallin.
Cauzzo et al. The effect of chemical structure on the photosensitizing efficiencies of porphyrins
Tanielian et al. Effect of aggregation on the hematoporphyrin‐sensitized production of singlet molecular oxygen
Hadjur et al. Photosensitization by hypericin: electron spin resonance (ESR) evidence for the formation of singlet oxygen and superoxide anion radicals in an in vitro model
Strauss et al. Photodynamic efficacy of naturally occurring porphyrins in endothelial cells in vitro and microvasculature in vivo
Rotomskis et al. Phototransformations of sensitizers 2. Photoproducts formed in aqueous solutions of porphyrins
König et al. Variation in the fluorescence decay properties of haematoporphyrin derivative during its conversion to photoproducts
Allen et al. A wavelength dependent mechanism for rose bengal-sensitized photoinhibition of red cell acetylcholinesterase
Daziano et al. Photophysical and redox properties of a series of phthalocyanines: relation with their photodynamic activities on TF‐1 and Daudi leukemic cells
Hu et al. Studies on the chelation of hypocrellin A with aluminium ion and the photodynamic action of the resulting complex
Viola et al. Electron paramagnetic resonance evidence of the generation of superoxide (O2.− and hydroxyl (. OH) radicals by irradiation of a new photodynamic therapy photosensitizer, Victoria Blue BO
Hadjur et al. Quantitative analysis of superoxide anion radicals photosensitized by hypericin in a model membrane using the cytochrome c reduction method
Itoh et al. Wavelength dependence of the geometric and structural photoisomerization of bilirubin bound to human serum albumin
Oliveros et al. Singlet oxygen (1Δg) sensitization and quenching by vitamin B12 derivatives